Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data Quantum-Si Inc files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
0
0
1.08
3.06
2.44
Cost of revenue
0
0
0.59
1.46
1.28
Gross profit
0
0
0.49
1.6
1.15
Research and development
28.1
27.6
46.6
72.1
67
59.6
53.8
Selling, general and administrative
9.14
50.3
42.3
44.6
50.5
44.8
Selling and marketing
0.63
1.15
3.96
General and administrative
7.88
7.98
46.4
Operating expenses
36.6
36.7
96.9
124
112
110
117
Operating income
-36.6
-36.7
-96.9
-124
-111
-109
-116
Interest expense
0
0.01
0.01
0
Interest income
0
0.46
9.64
8.96
Other non-operating income
0.01
-0.01
0.02
0.46
0.37
-0.02
0.96
Pre-tax income
-35.8
-36.6
-95
-132
-96
-101
-101
Income tax
0
0
0
0
0
0.06
0.06
Net income
-35.8
-36.6
-95
-132
-96
-101
-101
EBITDA
-35.8
-35.8
-95.9
-121
-107
-104
-112
EPS, basic
-6.95
-6.84
-1.19
-0.95
-0.68
-0.71
-0.51
EPS, diluted
-6.95
-6.84
-1.19
-0.95
-0.68
-0.71
-0.51
Shares, basic (weighted)
5.15
5.36
79.6
139
141
143
198
Shares, diluted (weighted)
5.15
5.36
79.6
139
141
143
198
Balance sheet
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
32.9
36.9
35.8
84.3
134
49.2
21.6
Short-term investments
0
436
160
141
Receivables
0
0.37
1.33
0.56
Inventory
0
3.95
4.07
3.2
Other current assets
0.95
5.87
6.87
4.26
3.01
4.55
Total current assets
37.9
477
358
266
218
176
Property, plant and equipment
2
8.91
16.8
16.3
16
13.2
Lease right-of-use assets
0
6.97
15.8
14.4
13.1
3.46
Goodwill
0
9.48
0
Intangible assets
0
0.53
0
Long-term investments
0
52.9
Other non-current assets
0
0.69
0.7
0.7
0.81
0.23
Total assets
40.6
503
391
298
248
246
Accounts payable
1.33
3.39
3.9
1.77
1.93
1.62
Accrued liabilities
0.51
2.68
5.55
4.94
5.33
5.9
Deferred revenue
0.19
0.1
Total current liabilities
2.75
11.5
15.7
11.6
18.2
23
Long-term debt
1.75
0
Lease liabilities
0
7.22
16.1
13.7
9.25
2.32
Other non-current liabilities
0
0.21
0
0.01
0.02
0.03
Total liabilities
4.5
26.2
32.8
26.6
32.5
25.4
Paid-in capital
12.5
744
758
767
812
918
Retained earnings
-172
-267
-400
-496
-597
-698
Other comprehensive income
0
0.05
-0.01
Shareholders' equity
-125
-160
477
359
272
215
220
Total equity
-125
-160
477
359
272
215
220
Total liabilities and equity
40.6
503
391
298
248
246
Cash flow statement
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-35.8
-36.6
-95
-132
-96
-101
-101
Depreciation and amortization
0.78
0.89
1.04
2.58
4.16
4.6
4.45
Stock-based compensation
2.72
1.92
24.9
11.2
8.52
8.89
10.8
Deferred income tax
0
0
0
0
Change in receivables
0
0
-0.37
-1.09
0.63
Change in inventory
0
0
0.29
4.34
-2.01
Change in payables
-0.27
0.54
0.71
0.72
-1.22
0.39
-0.34
Cash from operations
-30.7
-32.6
-66.8
-90.6
-94
-87.8
-94.7
Capital expenditures
-1.24
-0.46
-5.76
-10.7
-4.51
-4.58
-2.52
Acquisitions
0
0
-4.63
0
0
Purchases of investments
0
0
-441
-0.83
-124
-369
-405
Sales and maturities of investments
0
0
149
273
341
379
Cash from investing
-1.24
-0.46
-451
137
143
-32.7
-28.3
Stock issued
0.12
0.06
5.62
0
0
34.8
0
Cash from financing
18.2
37
517
1.91
0.15
35.9
95.4
Exchange rate effect
0
0
-0.03
0.01
Net change in cash
-13.7
3.98
-1.13
48.5
49.5
-84.6
-27.6
Free cash flow
-31.9
-33
-72.6
-101
-98.5
-92.4
-97.2
Income taxes paid
0
0
0.02
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $0.83 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
35.0%
Gross profit / revenue.
Operating margin
-6,888.0%
Operating income / revenue.
EBITDA margin
-6,589.0%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-6,144.0%
Pre-tax income / revenue.
Net margin
-6,138.0%
Net income / revenue.
FCF margin
-5,837.0%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-5,760.0%
Cash from operations / revenue.
Return on equity (ROE)
-54.7%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-50.9%
Net income / average total assets.
Return on invested capital (ROIC)
-55.8%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
3,436.0%
Research and development expense / revenue.
SG&A / revenue
2,529.0%
Selling, general and administrative expense / revenue.
Stock-based pay / revenue
693.5%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
77.3%
Capital expenditures / revenue.
D&A / revenue
298.9%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-20.3%
Revenue vs the same period a year earlier. Only from a positive base.
Gross profit growth, 1y
-27.9%
Gross profit vs the same period a year earlier. Only from a positive base.
Book value growth, 1y
2.2%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
-15.0%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y
-0.9%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-14.4%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
43.3%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
38.1%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
12.4%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
105.8%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
9.97x
Current assets / current liabilities.
Quick ratio
9.36x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
9.35x
(Cash + short-term investments) / current liabilities.
Days inventory + days sales outstanding - days payables.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$0.45
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$0.01
Revenue / diluted weighted shares.
FCF per share
-$0.43
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$0.42
Cash from operations / diluted weighted shares.
Book value per share
$0.83
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
114x
Market cap / revenue.
P/B
1.01x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
1.01x
Market cap / tangible book value, when positive.
EV/Sales
44.1x
Enterprise value / revenue.
FCF yield
-51.3%
Free cash flow / market cap.
Earnings yield
-54.0%
Net income / market cap (the inverse of P/E).
What was Quantum-Si Inc's revenue in fiscal 2025?
Quantum-Si Inc reported revenue of $2.4M for fiscal 2025, 20.3% lower than the year before.
Was Quantum-Si Inc profitable in fiscal 2025?
No. It reported a net loss of $101.3M.
How much free cash flow did Quantum-Si Inc generate in fiscal 2025?
Cash from operations of $94.7M minus capital expenditures of $2.5M left free cash flow of -$97.2M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.